CIA vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CIA exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.03. The stock is currently trading at $5.71, which is slightly above its Graham Number ($5.43) but significantly below its growth-based intrinsic value of $8.26. While explosive year-over-year earnings growth (99.5%) and consistent earnings beats provide a strong fundamental catalyst, the outlook is tempered by a heavily bearish technical trend (10/100) and a lack of dividend yield. The company is essentially a growth-oriented small-cap insurance play with strong momentum in earnings surprises but weak price action trends.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
CIA vs JPM: Head-to-Head Comparison
This page compares Citizens, Inc. (CIA) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.